Assessment of postoperative circulating tumour DNA to predict early recurrence in patients with stage I–III right-sided colon cancer: prospective observational study
KB Lygre, RB Forthun, T Høysæter, SM Hjelle… - BJS open, 2024 - academic.oup.com
Background Right-sided colon cancer (RCC) differs in mutation profile and risk of recurrence
compared to distal colon cancer. Circulating tumour DNA (ctDNA) present after surgery can …
compared to distal colon cancer. Circulating tumour DNA (ctDNA) present after surgery can …
[PDF][PDF] PROGNOSTIC IMPACT OF PROMOTER-HYPERMETHYLATED SFRP1 IN PANCREATIC DUCTAL ADENOCARCINOMA: A BLOOD-BASED BIOMARKER …
B Stubbe - 2024 - vbn.aau.dk
In Denmark approximately 1,000 individuals receive the diagnosis pancreatic ductal
adenocarcinoma (PDAC) annually. Due to its poor prognosis and increasing incidence …
adenocarcinoma (PDAC) annually. Due to its poor prognosis and increasing incidence …
ROLE OF cfDNA AND ctDNA TO IMPROVE THE RISK STRATIFICATION AND THE DISEASE FOLLOW-UP IN PATIENTS WITH ENDOMETRIAL CANCER: TOWARDS …
C Casas-Arozamena, A Vilar, J Cueva, E Arias… - medRxiv, 2024 - medrxiv.org
Introduction: In the past years, there has been a rise on advanced endometrial cancers (EC)
patients resulting in mortality increase. To overcome this trend, it is essential to improve the …
patients resulting in mortality increase. To overcome this trend, it is essential to improve the …